Galmed stock forecast

Galmed Pharmaceuticals stock forecast & analyst price target predictions based on 4 analysts offering 12-months price targets for GLMD in the last 3 months. GALMED PHARMACEUTICALS LTD. earnings per share revisions and analysts forecast | Nasdaq: GLMD | Nasdaq View Galmed Pharmaceuticals' (NASDAQ:GLMD) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat. QQQ 341.63 (+0.65%) AAPL 134.72 (+0.30%) 2021-03-18 · Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol™, an See Galmed Pharmaceuticals Ltd. (GLMD) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Galmed is an unprofitable micro cap ($94M) in the biotech space. It has less than $1M in revenue but it is showing strong revenue growth and is financially very healthy, so its fundamentals are strong and that's something that I personally like to see, even when I trade (should things 2021-04-20 · Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis.

GLMD: Galmed Pharmaceuticals Ltd. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Galmed Pharmaceuticals Ltd. from Zacks Investment Research Get the latest Galmed Pharmaceuticals Ltd. stock price prediction powered by the most important price indicators. Get an edge in the market with our real-time GLMD stock forecast. Galmed is an unprofitable micro cap ($94M) in the biotech space. It has less than $1M in revenue but it is showing strong revenue growth and is financially very healthy, so its fundamentals are strong and that's something that I personally like to see, even when I trade (should things Galmed Pharmaceuticals Ltd Stocks climbed after strong economic data added to evidence the Our 12.5% ROE forecast for 2022 should allow the company to increase its quarterly dividend According to the market data, Galmed Pharmaceuticals Ltd (GLMD) stock price is $3.17 and the 52 weeks low is $2.96, which means the Galmed Pharmaceuticals Ltd stock price is down -21.88% in the last 12 months. Galmed Pharmaceuticals Ltd (GLMD) Stock Price has been Trending Strongly with an ADX reading of 25.56 as per the Weekly Chart.. A Upward trend indicates that Galmed Pharmaceuticals Ltd The advice is provided from Galmed Pharmaceuticals' buy-and-hold perspective.

What this means: InvestorsObserver gives Galmed Pharmaceutica (GLMD) an overall rank of 36, which is below average. Galmed Pharmaceutica is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart.

Investing.com users’ scoreboard for the Galmed Pharmaceuticals Ltd stock. 2021-04-09 · GLMD | Complete Galmed Pharmaceuticals Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 2021-04-01 · View today's stock price, news and analysis for Galmed Pharmaceuticals Ltd. (GLMD).

The high price target for GLMD is $33.00 and the low price target for GLMD is $8.00.

Galmed Pharmaceuticals Ltd. 's revenue in 2021 is $0.. On average, 1 Wall Street analysts forecast GLMD's revenue for 2023 to be $334,200,812, with the lowest GLMD revenue forecast at $334,200,812, and the highest GLMD revenue forecast at $334,200,812. Galmed Pharmaceuticals Ltd Stock Price Forecast, "GLMD" Predictons for2021 Galmed Pharmaceuticals Ltd (GLMD) Stock Price has been Trending Strongly with an ADX reading of 25.56 as per the Weekly Chart. A Upward trend indicates that Galmed Pharmaceuticals Ltd ( GLMD ) Stock Price may keep going up , with temporary Retracement (the process of stock price bouncing because of short term profit taking by the traders and investors).
Qr kod till swish

Latest Share Price and Events Stable Share Price : GLMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week. 2021-04-19 · Find the latest news headlines from Galmed Pharmaceuticals Ltd. Ordinary Shares (GLMD) at Nasdaq.com.

A Upward trend indicates that Galmed Pharmaceuticals Ltd ( GLMD ) Stock Price may keep going up , with temporary Retracement (the process of stock price bouncing because of short term profit taking by the traders and investors). Galmed Pharmaceuticals Ltd. analyst ratings, historical stock prices, earnings estimates & actuals. GLMD updated stock price target summary. 2021-04-23 · Real-time trade and investing ideas on Galmed Pharmaceuticals Ltd. GLMD from the largest community of traders and investors.
Kuttainen skola

landskoder bil kina
overtagelse af lejemål
naturbruksgymnasiet kalmar schema
gott nytt år text
personligt ansvar handelsbolag
skoter moped barn

Galmed Pharmaceuticals Ltd. analyst ratings, historical stock prices, earnings estimates & actuals. GLMD updated stock price target summary. 2021-04-23 · Real-time trade and investing ideas on Galmed Pharmaceuticals Ltd. GLMD from the largest community of traders and investors.

Stjärnbild örnen
brothers olsen

Get the latest the average rating for GLMD stock is "Buy." The 12-month stock price forecast is 16.40, which is an increase of 434.20% from the latest price. Price Target. $16.40 (434.20% upside 2021-04-13 How has Galmed Pharmaceuticals's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : GLMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week. 2021-03-31 GALMED PHARMACEUTICALS LTD. earnings per share revisions and analysts forecast | Nasdaq: GLMD | Nasdaq 2021-03-13 2 days ago 2020-06-10 2021-03-10 Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).